RSB Spine, a Cleveland-based medical device company focused on developing spinal fusion products for degenerative disc disease, announced a 97 percent sales increase in 2010 versus 2009, according to a company news release.
The company also reported a 184 percent sales increase for the fourth quarter of 2010 as compared with the fourth quarter of 2009. John A. Redmond, CEO of RSB Spine, attributes the company's success to a unique product line and the execution of master distributor Paradigm BioDevices.
The company's InterPlate platform has gained market acceptance over the past year, which contributes to the company's success as well.
Read the RSB Spine release on the 4Q 2010 financial report.
Read other coverage on RSB Spine:
- RSB Spine's InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
- RSB Spine Sales Increase 38% for 2009
- FDA Approves RSB Spine's InterPlate C-Ti as an Anterior Cervical Plate
The company also reported a 184 percent sales increase for the fourth quarter of 2010 as compared with the fourth quarter of 2009. John A. Redmond, CEO of RSB Spine, attributes the company's success to a unique product line and the execution of master distributor Paradigm BioDevices.
The company's InterPlate platform has gained market acceptance over the past year, which contributes to the company's success as well.
Read the RSB Spine release on the 4Q 2010 financial report.
Read other coverage on RSB Spine:
- RSB Spine's InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
- RSB Spine Sales Increase 38% for 2009
- FDA Approves RSB Spine's InterPlate C-Ti as an Anterior Cervical Plate